b 213 750 (Niacin extended-release 750 mg)
Pill imprint b 213 750 has been identified as Niacin extended-release 750 mg.
Niacin is used in the treatment of high cholesterol; depression; niacin deficiency; hyperlipoproteinemia; hyperlipoproteinemia type iv, elevated vldl (and more), and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- b 213 750
- Strength:
- 750 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Miscellaneous antihyperlipidemic agents
Vitamins - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA Inc.
More about niacin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 55 Reviews – Add your own review/rating
- Drug class: miscellaneous antihyperlipidemic agents
Consumer resources
- Niacin
- Niacin capsules
- Niacin controlled-release capsules
- Niacin controlled-release tablets
- Niacin (Advanced Reading)
Other brands: Niaspan, Slo-Niacin, Niacin SR, Niacor, More... (3)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
